Erectile Dysfunction: An Underappreciated Warning Sign for Your Heart

Of men who die suddenly from cardiac causes, up to 90% have no preceding symptoms. Yet many may have had a warning sign hiding in plain sight.

With cardiovascular disease being the most common cause of death in men, the associated statistics are ominous. Of people who die suddenly from a cardiac cause, 70–90% are men — and half of them had no preceding symptoms to suggest they had cardiovascular disease. Despite decades of advances in preventive medicine, we still lack sufficient tools to predict who is at risk. An underappreciated warning sign is being increasingly recognized as deserving far more clinical attention: erectile dysfunction (ED).

The connection between erectile dysfunction and the heart is not obvious at first glance. There are multiple causes of ED, and not all of them involve blood flow. Men less than 40 years old are significantly more likely to have a psychogenic, non-vascular type of ED. As people enter their 40's, organic or vasculogenic ED becomes the majority, with at least 40% of those individuals with vasculogenic ED having an arterial etiology for their ED that may relate to overall cardiovascular disease.

When ED is vascular in origin, it shares much of the same underlying biology as coronary artery disease, and it often shows up first. Of importance, younger men with vasculogenic ED are substantially more likely to have clinically significant coronary artery disease as defined by sudden cardiac death, heart attack, and severe coronary artery disease on heart catheterization. Men in the 40–49-year-old range with ED had the highest relative incidence of coronary artery disease compared to similar aged men without ED, with the relative predictive value of ED decreasing with increasing age. Said another way, someone over 70 years old with vasculogenic ED has enough other risk factors that outweigh the predictive benefit of including ED into the decision process.

Why Would Erectile Dysfunction be a Warning Sign for Your Heart?

To understand the connection, consider the anatomy. The penile arteries are significantly smaller than the coronary arteries of a man. Potentially because smaller arteries show the effects of vascular disease earlier and more dramatically, ED caused by poor arterial blood flow often precedes overt coronary artery disease by two to five years.

In vasculogenic ED, the underlying biological changes are the same as those driving coronary disease: endothelial dysfunction, systemic inflammation, and accelerated platelet aggregation. If a man's penile arteries are narrowed and stiffened by the same process that causes atherosclerosis, it should not be surprising that his coronary arteries are heading in the same direction — they are often just a few years behind.

The implication is striking: some of the sudden cardiac deaths occurring in men who had no idea they had coronary disease might have been preventable, had more attention been paid to their hearts when the issue of ED first became apparent.

Think of vasculogenic ED as an early warning system — the penile arteries are sounding an alarm that the coronary arteries may soon follow.

Key Statistics You Should Know

50%	Of men who die suddenly from cardiovascular disease had no prior symptoms to suggest they were at risk.

2-5 yrs

Men with vasculogenic ED typically develop erectile symptoms 2-5 years before being diagnosed with coronary artery disease.

7x	Men under 40 with vasculogenic ED are seven times more likely to have significant coronary artery disease than those without ED.

1 in 10

Men with ED aged 40-59 will have undiagnosed diabetes compared to only 1 in 50 men without ED.

Not All ED Is Vascular — Understanding the Causes

It is important to recognize that ED has multiple potential etiologies, summarized in Table 1. The focus of this post is the vascular subset, which shares the most significant overlap with cardiovascular disease. But any evaluation of ED should consider the full picture.

Category	Description
Vasculogenic	Reduced blood flow to penile arteries; shares biology with coronary artery disease
Neurogenic	Nerve damage from diabetes, spinal injury, multiple sclerosis, or prior surgery
Hormonal	Low testosterone, thyroid disorders, elevated prolactin
Psychogenic	Anxiety, depression, relationship stress, performance concerns
Medication-induced	Antihypertensives, antidepressants, antiandrogens, and others
Structural / Anatomic	Peyronie disease, congenital anomalies

Table 1. Causes of Erectile Dysfunction

Shared Risk Factors: ED and Cardiovascular Disease

The conditions that predispose a man to cardiovascular disease overlap substantially with those that contribute to ED (Table 2). The metabolic syndrome — elevated fasting blood sugar, abdominal obesity, and hypertension — is strongly associated with both conditions. Diabetes deserves particular emphasis: while 1 in 50 men without ED aged 40–59 may have undiagnosed diabetes, 1 in 10 men with ED in that age range will have diabetes.

A word on testosterone: while low testosterone is frequently cited as a cause of ED, and supplementation is increasingly offered as a treatment, this often misses the underlying issue. In many overweight men, excess adipose tissue contains elevated levels of aromatase enzyme, which converts testosterone to estradiol. The resulting hormonal imbalance may produce symptoms attributable more to excess estrogen than to testosterone deficiency. Supplementing testosterone without addressing the underlying metabolic driver may not only be ineffective — it may be counterproductive. Current guidelines argue against supplemental testosterone when levels are normal.

Risk Factor	Clinical Relevance
Hypertension	Damages endothelium and reduces arterial compliance; common to both ED and CVD
Dyslipidemia	Promotes atherosclerosis in penile and coronary arteries alike
Diabetes mellitus	Tenfold higher ED prevalence; combined autonomic and vascular damage
Metabolic syndrome	Cluster of abdominal obesity, insulin resistance, and hypertension
Obesity	Reduces free testosterone via increased aromatase activity; raises estradiol
Tobacco use	Vasoconstriction and accelerated endothelial damage
Physical inactivity	Reduces vascular health and endogenous testosterone production
Obstructive sleep apnea	Intermittent hypoxia impairs endothelial function and testosterone levels

Table 2. Cardiovascular Risk Factors Shared with Erectile Dysfunction

From ED to Cardiac Risk Assessment: The Clinical Approach

Recent guidelines from the Princeton task force advocate a proactive approach when vasculogenic ED is identified (Figure 1). The recommended pathway is straightforward:

• Identify vasculogenic ED through structured clinical assessment

• Calculate 10-year cardiovascular risk using the AHA-PREVENT risk calculator

• If 10-year risk exceeds 5%: proceed to coronary artery calcium (CAC) scoring

• Use CAC results to guide intensity of cardiovascular risk factor management

The reason CAC scoring is so valuable in this context is that it can detect subclinical atherosclerosis — silent plaque in the coronary arteries — before symptoms develop. In a man with ED, a significantly elevated CAC score may be the difference between watchful waiting and initiating aggressive preventive therapy.

Figure 1. Clinical process from ED to considering coronary artery disease risk factor management.

The bottom line from current guidelines: ED in a man with cardiovascular risk factors should trigger a systematic cardiovascular evaluation — not simply a prescription.

Standardized Tools for Assessing Erectile Dysfunction

Because ED remains underreported and underappreciated, standardized assessment tools help clinicians open the conversation and quantify severity. Two instruments are particularly useful in practice.

The International Index of Erectile Function — Abbreviated (IIEF-5) is a validated 5-question tool (Table 3), scored 1 to 5 per question (total 5–25). A score of 21 or below indicates ED; a score of 11 or below suggests moderate-to-severe ED.

Q	Question
1	How do you rate your confidence that you could get and keep an erection?
2	When you had erections with sexual stimulation, how often were your erections hard enough for penetration?
3	When you attempted sexual intercourse, how often were you able to penetrate your partner?
4	During sexual intercourse, how often were you able to maintain your erection after you had penetrated your partner?
5	During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?

Table 3. International Index of Erectile Function — Abbreviated (IIEF-5)

For clinicians or patients seeking a lower-friction entry point, a single-question screener (Table 4) can be used to initiate the conversation.

"Over the past 6 months, how would you describe your confidence that you could get and keep an erection?"

Scoring guide:

• Very low / Low → Suggests significant ED — further evaluation warranted

• Moderate → Borderline; cardiovascular risk assessment recommended

• High / Very high → Likely sufficient erectile function

Table 4. Single-Question Screening Tool for ED 

What Can Be Done? Risk Factor Management Is the Foundation

There is no pharmacologic shortcut that reverses the underlying vascular disease driving vasculogenic ED. Medications, such as the little blue pill, improve symptoms by augmenting blood flow, but they may have little or no impact on the underlying arterial pathology. The interventions that can — and do — make a difference are the same ones that reduce cardiovascular risk:

• Smoking cessation

• Weight loss and management of abdominal obesity

• Glycemic control in diabetes or prediabetes

• Blood pressure optimization

• Regular structured aerobic exercise

• Stress reduction and treatment of depression or anxiety

• Statin therapy when indicated based on cardiovascular risk

Interestingly, the penile arteries are sized more like the microvasculature of the female coronary circulation. This has a practical implication: just as women with microvascular coronary disease cannot always be treated with stents or bypass surgery, vasculogenic ED may not be "fixable" — but it is preventable and manageable through aggressive risk factor modification.

ED may be among the most underutilized entry points into preventive cardiology — particularly in men who are otherwise asymptomatic and who would never otherwise present for cardiovascular evaluation.

The Bottom Line

Erectile dysfunction, particularly when vasculogenic in origin, is not simply a quality-of-life issue. It is a systemic vascular signal that deserves the same clinical attention we would give to exertional chest pain or an abnormal stress test.

Men should feel empowered to discuss ED with their physicians. And clinicians — whether in primary care, endocrinology, or cardiology — should be asking about it. If a man is experiencing ED, the right first response is not just a prescription. It is a conversation about his heart.

If you or someone you care about is experiencing ED, do not wait for chest pain to bring you in. The warning sign may already be present.

📅 Ready to Find Out Where You Stand?

Evexeya Health is accepting new patients now. Visit EvexeyaHealth.com or call our office to schedule a new patient consultation.

References:

• Burnett, A. L., et al. (2018). Erectile dysfunction: AUA guideline. The Journal of Urology, 200(3), 633–641. https://doi.org/10.1016/j.juro.2018.05.004.

• Caskurlu, T., et al. (2004). The etiology of erectile dysfunction and contributing factors in different age groups in Turkey. Int J Urology, 11(7), 525-9.

• Inman, B.A., et al. (2009). A Population-Based, Longitudinal Study of Erectile Dysfunction and Future Coronary Artery Disease. Mayo Clin Proc, 84(2), 108-113.

• Kloner, R. A., et al. (2024). Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. The Journal of Sexual Medicine, 21(1), 90–116. https://doi.org/10.1093/jsxmed/qdad163

• Koehler, T. S., et al. (2024). The Princeton IV consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings, nn(n), 1–18. https://doi.org/10.1016/j.mayocp.2024.06.002.

• Rew, K. T., et al. (2016). Erectile dysfunction. American Family Physician, 94(10), 820–827.

• Rosen, R. C., et al. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research, 11(6), 319–326.

• Schwartz, B. G., et al. (2011). Cardiovascular implications of erectile dysfunction. Circulation, 123(e609), e609–e611. https://doi.org/10.1161/CIRCULATIONAHA.110.017681

• Shamloul, R., et al. (2013). Erectile dysfunction. Lancet, 381(9861), 153-165.

• Thompson, I. M., et al. (2005). Erectile dysfunction and subsequent cardiovascular disease. JAMA, 294(23), 2996–3002.

This post is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for personalized guidance.

© Evexeya Health | Madison, WI | evexeyahealth.com